Elementis PLC
28 April 2008
Elementis - Acquisition of Deuchem Co., Ltd.
Elementis plc today announces that it has agreed, through its wholly owned
subsidiary Elementis Holdings Limited, to purchase Deuchem Co., Ltd.
('Deuchem'), a Taiwan based company, for a cash consideration of £40.4 million
(TW$ 2,464 million).
Deuchem was established in 1978 and is a leading supplier of additives and
resins to the coating and related industries, with three sales offices in
Taiwan and eleven sales offices in China, together with manufacturing and
technical facilities near Taipei and in Shanghai. The acquisition of Deuchem
will significantly expand Elementis' presence in Asia and provide a platform
for its Specialty Products Division to accelerate growth in the region.
In 2007, Deuchem's revenue grew by approximately 6.5 per cent, which is
consistent with the Elementis 2007 Asia Pacific performance. Further growth
in the combined businesses will be driven by the sale of Deuchem's product
portfolio to the Elementis global customer base, as well as the opportunity
to sell Elementis products through the well developed Deuchem sales and
technical support network in China and Taiwan.
The transaction is subject to regulatory approvals and the purchase price
assumes that Deuchem will have debt of up to £1.3 million at closing. Closing
is anticipated to take place during the second half of 2008 and the
transaction is expected to be earnings enhancing for Elementis in the first
full year of ownership.
Greg McClatchy, president of Elementis Specialties, will head the combined
organisation.
Deuchem's audited results for the year to December 31, 2007 are as follows:
Sales £37.9 m
Profit before tax £ 5.1 m
Profit after tax £ 3.6 m
EBITDA £ 5.7 m
Gross assets £36.1 m
David Dutro, Elementis' Chief Executive Officer, said 'This acquisition
represents a significant step in the evolution of Elementis and our commitment
to profitable growth in Specialties. Deuchem has established an impressive
reputation over the past thirty years for technical service and product
development, and is therefore an excellent fit with our Specialty Products
Division. Listening to customers' needs and working to meet them is a
philosophy that Deuchem and Elementis share. Deuchem has a strong presence
in Asia in terms of its commercial team, technical organization, and
manufacturing group, and when combined with the Elementis infrastructure
provides an enviable platform to drive growth. Deuchem's complementary product
portfolio, customer service culture, and the opportunity to leverage combined
technologies globally gives us confidence that this acquisition will create
shareholder value.'
Notes:
1) Elementis is acquiring Deuchem from Antony Chang (Chairman and CEO of
Deuchem), who is the largest shareholder, and from four other directors as well
as a number of other private shareholders, including employees who will remain
in the business.
2) Deuchem's senior management, with the exception of Antony Chang, is expected
to be retained.
3) Exchange rate used: £1 = TW$ 61.
Enquiries:
Elementis plc Tel: +44 (0)20 7408 9302
David Dutro, Group Chief Executive
Brian Taylorson, Finance Director
Financial Dynamics Tel: +44 (0)20 7831 3113
Andrew Dowler
Greg Quine
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.